Healthcare

Image

Europe Acute Coronary Syndrome Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Published Report
  • Mar 2022
  • Europe
  • 350 Pages
  • No of Tables: 64
  • No of Figures: 35

Europe Acute Coronary Syndrome Market, By Type (Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, and Unstable Angina), Diagnosis (Stress Test, Blood Tests, Imaging and Others), Treatment (Medication and Surgery), End User (Hospitals and Clinics, Diagnostic Centers, Academic Institutes and Others)-Industry Trends and Forecast to 2029.

Europe Acute Coronary Syndrome Market

Europe Acute Coronary Syndrome Market Analysis and Insights

Europe acute coronary syndrome market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.7% in the forecast period of 2022 to 2029 and is expected to reach USD 4,915.11 million by 2029. The major factors driving the growth of the acute coronary syndrome market are rise in prevalence of chronic diseases, such as coronary artery disease, ischemic heart disease, and vascular diseases, growing geriatric population, wide range of products offered by market players leading the acute coronary syndrome market to grow in future.

Europe Acute Coronary Syndrome Market

Europe Acute Coronary Syndrome Market

Acute coronary syndrome refers to a group of diseases in which blood flow to the heart decreases. Conditions related to ACS include ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina. It is a type of Coronary Heart Disease (CHD), which is responsible for one-third of total deaths in people older than 35. Some forms of CHD can be asymptomatic, but ACS is always symptomatic.

Acute coronary syndrome (ACS) is a manifestation of coronary heart disease (CHD) and usually a result of plaque disruption in coronary arteries (atherosclerosis). The common risk factors for the disease are smoking, hypertension, diabetes, hyperlipidemia, physical inactivity, family obesity, and poor nutritional practices. Cocaine abuse can also lead to vasospasm. A family history of early myocardial infarction (55 years of age) is also a high-risk factor.

Europe acute coronary syndrome market report provides details of market share, new developments, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, products approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Type (Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, and Unstable Angina), Diagnosis (Stress Test, Blood Tests, Imaging and Others), Treatment (Medication and Surgery), End User (Hospitals and Clinics, Diagnostic Centers, Academic Institutes and Others)

Countries Covered

Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey & Rest of Europe

Market Players Covered

AstraZeneca, Daiichi Sankyo company, Johnson & Johnson Service Inc., Amgen Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc, Sanofi, CSL Behring, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Baxter, Dr. Reddy’s Laboratories, Merck & Co., Inc. and Novartis AG and among others.

Europe Acute Coronary Syndrome Market Dynamics

Drivers

  • Rise in Prevalence of Chronic Diseases, such as Coronary Artery Disease, Ischemic Heart Disease, and Vascular Diseases

As the companies are constantly engaged in research and developmental activities, the knowledge about the prevalence of chronic heart and vascular diseases would help in finding novel solutions, and developing the cardiology and vascular devices would aid in more collaborations and partnerships with market players in the U.S., Europe, and Asia Pacific region. This signifies that the increase in research and development investment for the discovery and development of treatments of acute coronary syndrome boosts the market growth.

  • Growing Geriatric Population

The number of elderly people reporting respective cardiovascular diseases is high. Owing to this, it is anticipated that the ever-increasing geriatric population, which is expected to rise in future years worldwide mainly in Europe& Asia-Pacific region, creates an opportunity for market growth in the forecast period.

  • Wide Range of Products Offered by Market Players

Strategic product launches and collaborations done by major companies in interventional cardiology and peripheral vascular devices have opened up an opportunity to expand their business in various regions. This strategy is allowing the companies to strengthen their footprints in the market. Therefore, it is predicted that strategic initiative is the golden opportunity for the market players to accelerate their revenue growth in the market.

Opportunities

As technology advances rapidly, it improves how one manages cardiovascular diseases. In addition, recent healthcare monitoring applications and gadgets have enhanced the connection between patients and healthcare providers to update treatment plans and improve health outcomes. Thus, this is expected to create a significant opportunity for the global acute coronary syndrome market in the forecast period.

Also, governments in emerging markets (China, Brazil, Russia, India, and South Africa) reform public healthcare and grant more accessible access to medicine. These two factors working in unison mean greater freedom for market developments and increased innovation in clinical research in emerging markets.

Restraints/Challenges

Rise in cost of the therapeutic surgery and lack of accessibility of disease management services and support in low economic countries are the restrains and challenges for the growth of acute coronary syndrome market.

The increased intricacy and cost of the cardiology devices and robust investments would increase the costs. The increased cost would result in delayed treatment of the patients in hospitals and clinics and clearance of these product is very rigorous and time-consuming many of the products find it difficult to get approved due to not complying with the regulations which may hamper the market growth.

This acute coronary syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Acute Coronary Syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In November 2021, Merck, announced the successful completion of the acquisition of Acceleron Pharma Inc. It is an important and strategic opportunity for the company to continue growing their cardiovascular portfolio and pipeline that builds on long and proud legacy in cardiovascular disease and further bolsters the company’s business development strategy fueled by Acceleron’s groundbreaking research.

Europe Acute Coronary Syndrome Market Scope

Europe acute coronary syndrome market is categorized based on type, diagnosis, treatment and end user. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Type

  • Non-St-Elevation Myocardial Infarction
  • St-Elevation Myocardial Infarction
  • Unstable Angina

On the basis of type, the Europe acute coronary syndrome market is segmented into non-St-elevation myocardial infarction, St-elevation myocardial infarction and unstable angina.

Diagnosis

  • Stress Test
  • Blood Tests
  • Imaging
  • Others

On the basis of diagnosis, the Europe acute coronary syndrome market is segmented into stress test, blood test, imagining and others.

Treatment

  • Medication
  • Surgery

On the basis of treatment, the Europe acute coronary syndrome market is segmented into medication and surgery.

End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Academic Institutes
  • Others

Europe Acute Coronary Syndrome Market

On the basis of end user, the Europe acute coronary syndrome market is segmented into hospitals and clinics, diagnostic centers, academic institutes and others.

Acute Coronary Syndrome Market Regional Analysis/Insights

Europe acute coronary syndrome market is further segmented into major countries including Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey & Rest of Europe.

Germany in Europe dominates the acute coronary market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major players and well-developed healthcare infrastructure in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Europe brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Acute Coronary Syndrome Market Share Analysis

Europe acute coronary syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to acute coronary syndrome market.

Some of the prominent participants operating in the Europe acute coronary syndrome market are Movianto (U.S.), Sharp (U.S.),Thermo Fisher Scientific Inc.,(U.S.), Catalent, Inc (U.S.), PCI Pharma Services (U.S.), Almac Group (U.K.), PAREXEL International Corporation (U.S.), Bionical Ltd. (U.K.), Alium Medical Limited (U.K.), MYODERM (U.K.), Clinigen Group plc (U.K.), Ancillare, LP (U.S.), SIRO Clinpharm (India) CLINICAL SUPPLIES MANAGEMENT HOLDINGS, INC. (U.S.) Biocair (U.K.) and others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, GlobalVsRegional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


SKU-

TABLE 1 LIST OF RECENT PROGRESS OF 3D BIO PRINTING FOR CARDIAC TISSUE ENGINEERING-

TABLE 2 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 3 EUROPE NON-ST-ELEVATION MYOCARDIAL INFARCTION IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 EUROPE ST—ELEVATION MYOCARDIAL INFARCTION IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 EUROPE UNSTABLE ANGINA IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 EUROPE ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 7 EUROPE STRESS TEST IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 8 EUROPE BLOOD TEST IN ACUTE SYNDROME CORONARY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 EUROPE IMAGING IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 EUROPE OTHERS IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 12 EUROPE MEDICATION IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 EUROPE SURGERY IN ACUTE CORONARY SYNDROME MARKET, BY REGION 2020-2029 (USD MILLION)

TABLE 14 EUROPE ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 15 EUROPE HOSPITALS AND CLINICS IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE DIAGNOSTIC CENTERS IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 EUROPE ACADEMIC INSTITUTES IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE OTHERS IN ACUTE CORONARY SYNDROME MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE ACUTE CORONARY SYNDROME MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 20 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 EUROPE ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 22 EUROPE ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 23 EUROPE ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 24 GERMANY ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 GERMANY ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 26 GERMANY ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 27 GERMANY ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 28 FRANCE ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 FRANCE ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 30 FRANCE ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 31 FRANCE ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 32 U.K. ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 33 U.K. ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 34 U.K. ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 35 U.K. ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 36 ITALY ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 37 ITALY ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 38 ITALY ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 39 ITALY ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 40 RUSSIA ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 41 RUSSIA ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 42 RUSSIA ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 43 RUSSIA ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 44 SPAIN ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 45 SPAIN ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 46 SPAIN ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 47 SPAIN ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 48 TURKEY ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 49 TURKEY ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 50 TURKEY ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 51 TURKEY ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 52 NETHERLANDS ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 53 NETHERLANDS ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 54 NETHERLANDS ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 55 NETHERLANDS ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 56 SWITZERLAND ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 SWITZERLAND ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 58 SWITZERLAND ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 59 SWITZERLAND ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 60 BELGIUM ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 61 BELGIUM ACUTE CORONARY SYNDROME MARKET, BY DIAGNOSIS, 2020-2029 (USD MILLION)

TABLE 62 BELGIUM ACUTE CORONARY SYNDROME MARKET, BY TREATMENT, 2020-2029 (USD MILLION)

TABLE 63 BELGIUM ACUTE CORONARY SYNDROME MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 64 REST OF EUROPE ACUTE CORONARY SYNDROME MARKET, BY TYPE, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Europe Acute Coronary Syndrome Market will be projected to grow at a CAGR of 4.7% during the forecast by 2029.
The Europe Acute Coronary Syndrome Market will be projected at USD 4,915.11 million during the forecast by 2029.
The major players operating in the Europe Acute Coronary Syndrome Market are AstraZeneca, Daiichi Sankyo company, Johnson & Johnson Service Inc., Amgen Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc, Sanofi, CSL Behring, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Baxter, Dr. Reddy’s Laboratories, Merck & Co., Inc. and Novartis AG and among others.
The significant factors flourishing the growth of the Europe Acute Coronary Syndrome Market are Growing Geriatric Population and Rise in Prevalence of Chronic Diseases, such as Coronary Artery Disease, Ischemic Heart Disease, and Vascular Diseases.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials